Client Stories

Pharma groups to pay NHS £550m 'rebate'

NHS benefit from rebate

The National Health Service is to receive a £550m 'rebate' from the pharmaceuticals industry next year as part of a deal that drugmakers hope will spur faster adoption of new medicines in Britain. Pharma companies will pay the sum under an agreement that caps growth in the NHS budget for branded drugs, with the industry reimbursing any spending that overruns the cap. Almost £1bn has been paid since the deal was struck in 2013; this week pharma companies reached an agreement with the Department of Health to pay £550m in 2016. The sum includes £200m brought forward from the estimated rebates that would have been due in 2017 and 2018. The Association of the British Pharmaceutical Industry said it hoped the upfront payment would help overcome hurdles to the adoption of new medicines.


Note: News bulletin content has been provided by a third-party and is not the opinion of Santander

Other Articles

When you’re an established business, recruiting top talent in all the areas you need can seem like a never-ending challenge.


If you’re a start-up or small business, how can you put together an attractive employee package to appeal to top talent – graduate and…


Mexico is predicted to become one of the world’s top 10 economies in the next 10 or 20 years.

Stop fraud

More than one million incidents of financial fraud occurred in the first six months of 2016, according to official figures released by…

Santander’s Head of SME International Mark Collings discusses why exporting to new global markets may provide businesses with new and…

Where Next?